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Human myiasis caused by bot ﬂ  ies of nonhuman ani-
mals is rare but may be increasing. The treatment of choice 
is laser photocoagulation or vitrectomy with larva removal 
and intraocular steroids. Ophthalmomyiasis caused by Hy-
poderma spp. should be recognized as a potentially revers-
ible cause of vision loss.
O
phthalmomyiasis interna is invasion of the globe by 
larvae of any species of oestrid ﬂ  ies; ophthalmomyia-
sis externa involves only the external ocular structures (1). 
Dermatobia hominis, endemic to tropical or subtropical ar-
eas, and Oestrus ovis (sheep bot ﬂ  y) cause most cases of 
ophthalmomyiasis (2). Both typically cause ophthalmomy-
iasis externa (2). Only 2 bot ﬂ  ies inhabit Nearctic circum-
polar regions: the Caribou bot ﬂ  y (Hypoderma tarandi) and 
the Caribou nasal bot ﬂ  y (Cephenemyia trompe), a nonhu-
man pathogen (2). H. tarandi is a nonbiting ﬂ  y whose obli-
gate endoparasitic larvae typically affect caribou through-
out their circumpolar range (2,3). From late June to early 
September. the ﬂ  y lays eggs directly on the guard hairs of 
the caribou (2,3). Once deposited, eggs hatch into larvae 
that penetrate skin (3). They move subcutaneously to reach 
the animal’s dorsal region, where they cut breathing holes 
and are encased within granulomatous cysts, termed war-
bles. There they develop for 9–11 months; in May or June 
of the following year, they leave the animal and pupate on 
the ground (3). Mated adult females are capable of long 
ﬂ  ights (≈900 km) in search of suitable hosts (3).
Infestations by H. tarandi in humans are rare but are 
likely underreported (4). Related species, H. bovis and 
H. lineatum, inhabit various regions of North America, 
Europe, and Asia and have also been implicated in human 
disease (2,5). A third species that affects cattle and yaks in 
China (H. sinense) is also responsible for human infesta-
tions (2). The pathophysiology of human ophthalmomyiasis 
by Hypoderma spp. is not known. Eyebrows and eyelashes 
have been suggested as possible targets for oviposition (3). 
Oviposition on human scalp hair has been achieved experi-
mentally and could be the preferential site in humans (3). 
An alternative explanation is transfer of the larvae directly 
from the guard hairs of the caribou to the human eye or skin 
through close contact with animal pelts. The parasite does 
not appear to complete its life cycle in humans (1,2).
We present the ﬁ  rst, to our knowledge, 2 published 
cases of ophthalmomyiasis interna caused by H. tarandi in 
Canada. Furthermore, we present the ﬁ  rst published use of 
Hypoderma spp. serologic testing to assist in the diagnosis 
of myiasis in humans.
The Cases and Literature Review
The ﬁ  rst patient was a 41-year-old woman from Rankin 
Inlet, Nunavut, Canada, who noticed ﬂ  oaters (objects in the 
ﬁ  eld of vision that originate in the vitreous) in her right eye 
in August 2006. Initial funduscopic examination showed 
posterior vitreous detachment. Two weeks later, her vision 
was more impaired; repeat funduscopy showed panuveitis. 
Pretreatment blood count was within normal limits with no 
eosinophilia. Topical steroids were ineffective. At a third 
assessment, her visual acuity was 20/400; funduscopic ex-
amination showed an intraocular larva (Figure 1). The par-
asite appeared to recede behind the retina and could not be 
photocoagulated. A pars plana vitrectomy and intraocular 
laser treatment of the entry and exit sites were performed. 
Triamcinolone (0.4 mg) was administered for intraocular 
inﬂ  ammation, and antibiotics were given as prophylaxis. 
The larva was not recovered. Postoperative magnetic reso-
nance imaging demonstrated no parasite or abnormality. 
The larva was assumed to be that of H. tarandi because of 
its appearance (shape, size, and segments), the late summer 
timing, and the patient’s residence in the subArctic. Sero-
logic testing for H. tarandi by Western blot, as described 
by Baron and Colwell, was performed (6). Six weeks after 
symptom onset, serum was positive for immunoglobulin 
(Ig) G, IgE, and IgM to hypodermin C, a larval collagenase 
of H. tarandi (7). No seroreactivity to the hypodermins A 
and B of H. lineatum was observed. Because the larva was 
unrecoverable, the patient was treated with 1 oral dose (9 
mg) of ivermectin (Merck & Co., Kirkland, Quebec, Can-
ada) 1 week after vitrectomy. After 6 months, her visual 
acuity had improved to 20/30.
The second patient was an 11-year-old Inuit boy from 
Chesterﬁ  eld Inlet, Nunavut, Canada, who was examined in 
October 1997 because of a painful right eye, scleral red-
ness, and blurry vision. Examination found uveitis and 
glaucoma. Topical steroid therapy was begun, after which 
retinal detachment, hemorrhages, and a 4-mm larva in the 
subretinal space were noted. Blood work showed marginal 
eosinophilia; computed tomographic examination of the 
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brain and orbits showed no abnormalities. The larva was 
removed by pars plana vitrectomy and retinotomy. Ex-
amination of the larva by dissection microscopy showed a 
4 × 1–mm larva. Scanning electron microscopy, performed 
according to Colwell et al. (8), conﬁ  rmed the characteristic 
of the ﬁ  rst instar of Hypoderma spp., i.e., mouth hooks, 
anterior sensory structure, spines, and spiracles (Figure 2). 
The presence of only 2 lateral spines per spiracle indicated 
H. tarandi. Western blot testing showed the presence of 
IgG only to hypodermin C. When asked about his expo-
sure to caribou, the boy admitted to tracking, hunting, and 
skinning caribou. The patient’s disease progressed despite 
therapy, and his eye was enucleated. Pathologic examina-
tion showed retinal detachment, eosinophilic choroiditis, 
and retinitis. Chronic nongranulomatous inﬂ  ammation was 
noted in the ciliary body and iris. No additional larvae were 
found.
We searched the literature, using PubMed, for the 
terms “ophthalmomyiasis” with limits “human” and “Eng-
lish.” We also reviewed references of selected publica-
tions. We reviewed only cases of ophthalmomyiasis interna 
caused by oestrid ﬂ  ies found in North America, which were 
conﬁ  rmed by visible larvae (online Appendix Table, avail-
able from www.cdc.gov/EID/content/14/1/64-appT.htm). 
Demographics and clinical presentation of patients are in 
the Table. For statistical analysis, outcomes were separated 
into good (vision unchanged from baseline or better than 
20/80), moderate (able to see shapes or ﬁ  ngers or vision 
worse than 20/80 but not blind), and severe (able only to 
see light or movement, completely blind or enucleated). 
Although moderate or severe vision loss appeared to oc-
cur more commonly with Hypoderma than Cuterebra in-
festations (53.3% vs 14.3%), this frequency was not sta-
tistically signiﬁ  cant (p = 0.08). Photocoagulation appeared 
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Figure 1. A) Retinal hemorrhages visible on funduscopic 
examination of right eye of a 41-year-old woman, Nunavut, Canada, 
with ophthalmomyiasis interna. B) Segmented 3-mm larva with a 
cylindrical body, no visible spines, and indistinguishable anterior 
and posterior ends in the vitreous cavity, corresponding to the ﬁ  rst 
instar of Hypoderma tarandi.
Figure 2. Scanning electron microscope images of the parasite 
from an 11-year-old Inuit boy, Nunavut, Canada. A) Anterior end 
of the maggot. The cephalic segment is evident; mouth and mouth 
hooks are present (boxed). Scale bar = 50 μm. B) The characteristic 
cephalic sensory array (boxed). Scale bar = 10 μm. C) Posterior 
segments of the maggot. Scale bar = 100 μm. D) Spiracular 
openings on the posterior segments of the maggot characteristic of 
ﬁ  rst instar of Hypoderma. Scale bar = 10 μm.to produce better outcomes (80% good outcomes) than no 
intervention (73.7% good outcomes) or surgical removal/
vitrectomy (41.2% good outcomes); however, χ2 analysis 
showed no statistically signiﬁ  cant difference (p = 0.121). 
This observation may suggest that by the time the patient 
seeks treatment, damage to ocular structures has already 
occurred. Recent cases have been treated with photocoagu-
lation or vitrectomy and intraocular steroid administration. 
Although no speciﬁ  c intervention is associated with bet-
ter outcomes, given the difﬁ  culty in studying outcomes in 
this rare condition and the success of this therapy for other 
foreign bodies in the eye, this course of action is reason-
able. Ivermectin as medical therapy for ophthalmomyiasis 
interna has not been reported, but it is effective as therapy 
and prophylaxis for bot ﬂ  y infestation of livestock (9). Iver-
mectin as adjunctive therapy in select cases of ophthalmo-
myiasis may be of beneﬁ  t, but evidence is lacking. Only 
1 case of ophthalmomyiasis externa caused by D. hominis 
and treated with ivermectin has been reported (10).
Conclusions
Human myiasis caused by bot ﬂ  ies of nonhuman ani-
mals is rarely reported. However, diagnoses may increase 
as a result of increasing population in northern latitudes, 
encroachment into habitats with natural hosts like caribou, 
and better access to ophthalmologists. The treatment of 
choice seems to be laser photocoagulation or vitrectomy 
with larva removal and coadministration of intraocular ste-
roids. In areas where Hypoderma spp. are common, health-
care providers should consider this condition and promptly 
refer patients to an ophthalmologist.
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Table. Demographics and clinical presentation of 32 patients with 
ophthalmomyiasis interna* 
Characteristic No. (%) 
Symptom 
  Red eye  21 (60) 
  Vision loss  24 (68) 
 Floaters    24  (68) 
  Eye pain  6 (17) 
 Scotomas  3  (9) 
Sex 
 Male  27  (77) 
 Female  7  (20) 
Loss of vision 
  Severe or total†   12 (34) 
  Moderate   2 (6) 
  Mild or none  19 (54) 
*Patients identified during literature search and described in the online 
Appendix Table. Mean patient age was 25.2 y; median, 16 y. 
†Includes blindness caused by enucleation. 
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